Garnet Biotherapeutics News
Most Popular Garnet Biotherapeutics Story
Garnet Bio gains $10.4M for cell-based therapies
Safeguard Scientifics says it joined a group of investors who ponied up $10.4 million to finance the development work underway at Garnet Biotherapeutics. Other investors include Alliance Technology Read more...
Latest Headlines
- January 29, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
